News

Asian Paints Limited will hold a board meeting on Thursday, 29th October 2026, to consider audited standalone financial results for the quarter and half-year ended 30th September 2026, unaudited consolidated financial results for the same period, and a potential interim dividend for the financial year ending 31st March 2027, with a record date of Wednesday, 4th November 2026. The trading window for designated persons, closed since Friday, 18th September 2026, will remain closed until Monday, 2nd November 2026, and the company will host an investor conference on Thursday, 29th October 2026, at 5 p.m. IST.

Asian Paints Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for trading in the company`s securities will be closed from Friday, September 18, 2026, until two trading days from the date of declaration of audited standalone and unaudited consolidated financial results for the quarter and half-year ending September 30, 2026.

Asian Paints announced the appointment of Leo Puri as an Additional and Independent Director, effective September 7, 2026, for a term of five years, subject to shareholder approval. Additionally, the Board appointed Leo Puri as Chairman, effective January 23, 2027, succeeding R. Seshasayee, who had served as Chairman since October 1, 2023, until January 22, 2027. Mr. Puri, 65, currently serves as Advisory India Chair at Apax and holds board positions at Fortis Healthcare Limited, Dr. Reddy’s Laboratories Limited, and Amadeus IT Group.

Asian Paints announced the appointment of Leo Puri as an Additional and Independent Director, effective September 7, 2026, for a term of five years, subject to shareholder approval. Additionally, the Board appointed Leo Puri as Chairman, effective January 23, 2027, succeeding R. Seshasayee, whose term as Chairman concludes on January 22, 2027; this appointment is also subject to shareholder approval. Leo Puri, 65, currently serves as Advisory India Chair at Apax and holds board positions at Fortis Healthcare Limited, Dr. Reddy’s Laboratories Limited, and Amadeus IT Group, and previously held leadership roles at JP Morgan Chase, UTI Asset Management Company Limited, Warburg Pincus, and McKinsey & Company.

A disclosure document dated August 11, 2026, reveals that promoters and related entities of a company hold a significant number of shares, totaling approximately 83.34 million, but none are currently pledged. Key entities, including Satyadharma Investments and Trading Company Private Ltd, Castle Investment & Industries Private Limited, and Lyon Investment & Industries Private Limited, hold substantial portions of the total shares, ranging from 19.1% to 15.0%. The document details a complex ownership structure involving numerous private limited companies, trusts, and individual promoters, and serves as a transparency measure for regulatory bodies or lenders. The total share count used for percentage calculations is assumed to be 83,34,280, and the disclosure does not indicate any current risk associated with pledged shares.